Arq Publishes its First-Ever ESG Report
September 25, 2024 08:15 ET
|
Arq, Inc.
GREENWOOD VILLAGE, Colo., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Arq, Inc. (NASDAQ: ARQ) (the "Company" or "Arq"), a producer of activated carbon and other environmentally efficient carbon products,...
NEWTON GOLF Introduces New Gravity Putter Line, Building on Momentum from Recent Rebranding
September 25, 2024 08:15 ET
|
Sacks Parente Golf, Inc.
Gravity, the putter division of parent company NEWTON GOLF, introduces five putters in its new premium series CAMARILLO, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NEWTON GOLF, (Nasdaq: SPGC)...
FinWise Bancorp Announces Strategic Lending Program with PowerPay to Offer Transparent and Affordable Monthly Payments for Home Improvement and Elective Healthcare Purchases
September 25, 2024 08:15 ET
|
FinWise Bank
MURRAY, Utah, Sept. 25, 2024 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced the launch of a new...
Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock
September 25, 2024 08:15 ET
|
Windtree Therapeutics
Istaroxime significantly improved primary endpoint of the systolic blood pressure profile over six hours and showed significant improvements in many secondary endpoint assessments Study results to be...
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
September 25, 2024 08:00 ET
|
Centogene NV
Rostock International Parkinson's Disease (ROPAD) Study demonstrates a significant link between the RAB32 gene variant and Parkinson's disease, further supporting recent findingsData from over...
Aprea Therapeutics to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
September 25, 2024 08:00 ET
|
Aprea Therapeutics
DOYLESTOWN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology...
TTM Technologies, Inc. wins Cisco 2024 Supply Chain Security Champion Award
September 25, 2024 08:00 ET
|
TTM Technologies, Inc.
SANTA ANA, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology solutions including mission systems, radio frequency...
Synchronoss Introduces Enhanced Version of Flagship Personal Cloud Platform for Service Providers
September 25, 2024 08:00 ET
|
Synchronoss Technologies, Inc.
New Synchronoss Personal Cloud Adds Features Such as Memories and Built-In AI Functionality to Make it Even Easier for Subscribers to Optimize Content
Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis
September 25, 2024 08:00 ET
|
Palisade Bio, Inc.
– Completion of nonclinical safety and toxicity studies, Phase 1 clinical trial design and established Maximum Recommended Starting Dose – Completion of pre- Clinical Trial Application (CTA)...
Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension
September 25, 2024 08:00 ET
|
Mineralys Therapeutics, Inc.
– On track to announce topline data in Q1 2025 – – Virtual KOL event scheduled on October 30th to discuss the unmet need in hypertension, as well as a review of the ongoing pivotal clinical program...